Healthcare -
Biotechnology - NASDAQ - US
$ 3.35
0.601 %
$ 2.33 M
Market Cap
0.0
P/E
RNAZ - INTEREST INCOME & EXPENSE
Interest Income & Expense RNAZ - TransCode Therapeutics, Inc.
50.6 K
LAST VALUE
-27.04%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR